Insiders Acelyrin, Inc.

Equities

SLRN

US00445A1007

Market Closed - Nasdaq Other stock markets 01:30:00 13/06/2024 am IST			5-day change	1st Jan Change
4.61 ^USD	-4.36%		+11.08%	-38.20%

05/06	Transcript : Acelyrin, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 01:00 PM
05/06	ACELYRIN, Inc. Announces Positive 16-Week Data from its Global Phase 2b/3 Trial of Izokibep in Psoriatic Arthritis to Be Shared During Late-Breaking Oral Presentation at EULAR 2024	CI

Insiders

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Acelyrin, Inc. Announces Ron Oyston to Step Down as Chief People Officer, Effective August 15, 2024	09/05	CI
Acelyrin, Inc. Announces CEO Changes	09/05	CI
Acelyrin, Inc. Announces Leadership Transition	09/05	CI
Madrigal Pharmaceuticals Names New CFO	28/02	MT
Acelyrin, Inc. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communications	16/02	CI
Acelyrin, Inc. Appoints Lynn Tetrault to Board of Directors	21/12	CI
Acelyrin, Inc. Appoints Patricia Turney as Chief Technical Operations Officer	06/11	CI
Acelyrin, Inc. Appoints Shephard Mpofu as Senior Vice President of Development	03/23/03	CI
Acelyrin, Inc. Appoints Gil Labrucherie as Full Time Chief Financial Officer	22/23/22	CI
Acelyrin, Inc. Announces Resignation of Mardi C. Dier as Chief Financial Officer Effective August 15, 2023	03/23/03	CI
Acelyrin, Inc. Announces Resignation of Mardi C. Dier as Chief Business Officer Effective August 15, 2023	03/23/03	CI
ACELYRIN, INC. Appoints Ken Lock as Chief Commercial Officer	18/23/18	CI
Insider Buy: Acelyrin	12/23/12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer